Search results (94)
« Back to NewsNew research will map the impact of sleep and circadian rhythm disruption on cardiometabolic disease
4 June 2025
In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems have a role to play in this ‘cardiometabolic multimorbidity’, but its exact nature is under-researched.
Diabetes UK Early Career Investigator Award for Dr Thomas Hill
30 April 2025
Congratulations to Dr Thomas Hill who has received a Diabetes UK Early Career Investigator Award at the Diabetes UK Professional Conference.
Daniela Nasteska showcases diabetes research in new Oxford Sparks video
29 April 2025
RDM’s Dr Daniela Nasteska introduces the colourful world of diabetes research via a brand-new video produced by Oxford Sparks.
2024 RDM Graduate Citizenship Award Winners
6 February 2025
Congratulations to the winners of the 2024 RDM Graduate Citizenship Award; Megan Payne and Charlotte Frazer-Morris.
RDM researchers at IF Oxford Science and Ideas Festival
19 November 2024
Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
24 October 2024
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found
10 September 2024
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.
Jeremy Tomlinson awarded Outstanding Chief Investigator in NIHR celebration
23 July 2024
Congratulations to Professor Jeremy Tomlinson on winning an award for ‘Outstanding Chief Investigator’ from the National Institute of Health and Care Research’s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).
Senior Fellowship awarded to Costas Christodoulides
4 July 2024
Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.
Professor Rajesh Thakker receives OBE in King’s Birthday Honours
17 June 2024
Congratulations to RDM’s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King’s Birthday Honours 2024.
The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment
16 April 2024
The first participant has completed initial study activities and is now randomised to one of the trial’s arms.
Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement
6 March 2024
The American Diabetes Association (ADA) has announced this year's National Scientific and Health Care Achievement Award recipients.
Race to cure type 1 diabetes gets a new boost
7 December 2023
RDM group awarded £2.55 million for diabetes research.